Cargando…

Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction

BACKGROUND: Left ventricular hypertrophy and heart failure with preserved ejection fraction (HFpEF) are primary manifestations of the cardiorenal syndrome in patients with chronic kidney disease (CKD). Therapies that improve morbidity and mortality in HFpEF are lacking. Cell-based therapies promote...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieger, Angela C, Tompkins, Bryon A, Natsumeda, Makoto, Florea, Victoria, Banerjee, Monisha N, Rodriguez, Jose, Rosado, Marcos, Porras, Valeria, Valasaki, Krystalenia, Takeuchi, Lauro M, Collon, Kevin, Desai, Sohil, Bellio, Michael A, Khan, Aisha, Kashikar, Nilesh D, Landin, Ana Marie, Hardin, Darrell V, Rodriguez, Daniel A, Balkan, Wayne, Hare, Joshua M, Schulman, Ivonne Hernandez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895493/
https://www.ncbi.nlm.nih.gov/pubmed/35641169
http://dx.doi.org/10.1093/stcltm/szab004